Emergent BioSolutions to Participate in Investor Conferences
Emergent BioSolutions (NYSE: EBS) will attend several key investor conferences, including the IDEAS Midwest Conference (Aug 25-26) and the Wells Fargo Virtual Healthcare Conference (Sept 9-10).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Emergent BioSolutions (NYSE: EBS) will attend several key investor conferences, including the IDEAS Midwest Conference (Aug 25-26) and the Wells Fargo Virtual Healthcare Conference (Sept 9-10). Key activities include pre-recorded presentations and 1-on-1 meetings. The company aims to discuss recent developments and financial guidance during these events. Emergent BioSolutions focuses on protecting public health and plans to enhance the lives of 1 billion people by 2030. For further details, visit their website.
Details
News Market Reaction – EBS
The recorded move for EBS in the trading session of this news was -1.43%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:
- Three Part Advisors IDEAS Midwest Conference
August 25-26, 2021
Pre-recorded presentation available on August 26; 1-on-1 meetings on August 26
- Wells Fargo 2021 Virtual Healthcare Conference
September 9-10, 2021
Fireside chat on September 9 at 9:20 am ET; 1-on-1 meetings all day
- Morgan Stanley 19th Annual Global Healthcare Conference
September 9-10 & 13-15, 2021
Fireside chat on September 9 at 3:30 pm ET; 1-on-1 meetings all day
- Baird’s 2021 Global Healthcare Conference
September 14-15, 2021
Fireside chat on September 14 at 4:55 pm ET; 1-on-1 meetings all day
- Singular Research Compelling Values Webinar
September 16, 2021
Company presentation schedule will be posted on website
- Cantor 2021 Virtual Global Healthcare Conference
September 27-30, 2021
Fireside chat on September 27 at 4:00 pm ET; 1-on-1 meetings all day
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcast will be available both live, if possible, and by replay, and will be accessible from the Emergent website.
About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com
Media Contact:
Matt Hartwig
Director, Media Relations
hartwigm@ebsi.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.